Accendra Health Inc (ACH)vsCencora Inc. (COR)
ACH
Accendra Health Inc
$1.96
-3.45%
HEALTHCARE · Cap: $180.39M
COR
Cencora Inc.
$326.91
-1.46%
HEALTHCARE · Cap: $65.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 11695% more annual revenue ($325.78B vs $2.76B). COR leads profitability with a 50.0% profit margin vs -39.9%. ACH appears more attractively valued with a PEG of 0.70. COR earns a higher WallStSmart Score of 62/100 (C+).
ACH
Hold45
out of 100
Grade: D+
COR
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ACH.
Margin of Safety
-44.0%
Fair Value
$253.90
Current Price
$326.91
$73.01 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Every $100 of equity generates 134 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 118.0%
Large-cap with strong market position
Growing faster than its price suggests
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 2.9%
ROE of -163.8% — below average capital efficiency
Premium valuation, high expectations priced in
Trading at 33.3x book value
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ACH
The strongest argument for ACH centers on PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.
Bull Case : COR
The strongest argument for COR centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 50.0% and operating margin at 118.0%. PEG of 0.82 suggests the stock is reasonably priced for its growth.
Bear Case : ACH
The primary concerns for ACH are EPS Growth, Market Cap, Operating Margin.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Price/Book, Free Cash Flow. A P/E of 40.2x leaves little room for execution misses.
Key Dynamics to Monitor
ACH profiles as a turnaround stock while COR is a mature play — different risk/reward profiles.
ACH carries more volatility with a beta of 1.29 — expect wider price swings.
COR is growing revenue faster at 5.5% — sustainability is the question.
ACH generates stronger free cash flow (55M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 45/100), backed by strong 50.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Accendra Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?